186 related articles for article (PubMed ID: 35138899)
1. Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.
Benbarche S; Lopez CK; Salataj E; Aid Z; Thirant C; Laiguillon MC; Lecourt S; Belloucif Y; Vaganay C; Antonini M; Hu J; da Silva Babinet A; Ndiaye-Lobry D; Pardieu B; Petit A; Puissant A; Chaumeil J; Mercher T; Lobry C
Sci Adv; 2022 Feb; 8(6):eabg9455. PubMed ID: 35138899
[TBL] [Abstract][Full Text] [Related]
2. ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.
Thirant C; Ignacimouttou C; Lopez CK; Diop M; Le Mouël L; Thiollier C; Siret A; Dessen P; Aid Z; Rivière J; Rameau P; Lefebvre C; Khaled M; Leverger G; Ballerini P; Petit A; Raslova H; Carmichael CL; Kile BT; Soler E; Crispino JD; Wichmann C; Pflumio F; Schwaller J; Vainchenker W; Lobry C; Droin N; Bernard OA; Malinge S; Mercher T
Cancer Cell; 2017 Mar; 31(3):452-465. PubMed ID: 28292442
[TBL] [Abstract][Full Text] [Related]
3. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
Aid Z; Robert E; Lopez CK; Bourgoin M; Boudia F; Le Mene M; Riviere J; Baille M; Benbarche S; Renou L; Fagnan A; Thirant C; Federici L; Touchard L; Lecluse Y; Jetten A; Geoerger B; Lapillonne H; Solary E; Gaudry M; Meshinchi S; Pflumio F; Auberger P; Lobry C; Petit A; Jacquel A; Mercher T
Leukemia; 2023 Mar; 37(3):571-579. PubMed ID: 36585521
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathways driven by ETO2-GLIS2 in aggressive pediatric leukemia.
Thirant C; Lopez C; Malinge S; Mercher T
Mol Cell Oncol; 2017; 4(6):e1345351. PubMed ID: 29209645
[TBL] [Abstract][Full Text] [Related]
5. [Pediatric de novo acute megakaryoblastic leukemia: an affair of complexes].
Lopez CK; Mercher T
Med Sci (Paris); 2018 Nov; 34(11):954-962. PubMed ID: 30526836
[TBL] [Abstract][Full Text] [Related]
6. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract][Full Text] [Related]
7. Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.
Lopez CK; Noguera E; Stavropoulou V; Robert E; Aid Z; Ballerini P; Bilhou-Nabera C; Lapillonne H; Boudia F; Thirant C; Fagnan A; Arcangeli ML; Kinston SJ; Diop M; Job B; Lecluse Y; Brunet E; Babin L; Villeval JL; Delabesse E; Peters AHFM; Vainchenker W; Gaudry M; Masetti R; Locatelli F; Malinge S; Nerlov C; Droin N; Lobry C; Godin I; Bernard OA; Göttgens B; Petit A; Pflumio F; Schwaller J; Mercher T
Cancer Discov; 2019 Dec; 9(12):1736-1753. PubMed ID: 31662298
[TBL] [Abstract][Full Text] [Related]
8. ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network.
Wheat JC; Steidl U
Cancer Cell; 2017 Mar; 31(3):307-308. PubMed ID: 28292433
[TBL] [Abstract][Full Text] [Related]
9. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
10. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
12. The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program.
Fagnan A; Aid Z; Baille M; Drakul A; Robert E; Lopez CK; Thirant C; Lecluse Y; Rivière J; Ignacimouttou C; Salmoiraghi S; Anguita E; Naimo A; Marzac C; Pflumio F; Malinge S; Wichmann C; Huang Y; Lobry C; Chaumeil J; Soler E; Bourquin JP; Nerlov C; Bernard OA; Schwaller J; Mercher T
Hemasphere; 2024 Jun; 8(6):e90. PubMed ID: 38903535
[TBL] [Abstract][Full Text] [Related]
13. [Novel ETO2-GLIS2 fusion and therapeutic strategy in acute megakaryoblastic leukemia].
Thiollier C; Pflumio F; Ballerini P; Crispino JD; Bernard O; Mercher T
Med Sci (Paris); 2012 Nov; 28(11):1013-6. PubMed ID: 23171910
[No Abstract] [Full Text] [Related]
14. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
[TBL] [Abstract][Full Text] [Related]
15. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
Fang F; Lu J; Sang X; Tao YF; Wang JW; Zhang ZM; Zhang YP; Li XL; Xie Y; Wu SY; Chu XR; Li G; Wu D; Chen YL; Yu JJ; Jia SQ; Feng CX; Tian YY; Li ZH; Ling J; Hu SY; Pan J
J Exp Clin Cancer Res; 2022 Jul; 41(1):225. PubMed ID: 35842703
[TBL] [Abstract][Full Text] [Related]
16. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
17. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
[TBL] [Abstract][Full Text] [Related]
18. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
19. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
[TBL] [Abstract][Full Text] [Related]
20. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.
Wong RWJ; Ngoc PCT; Leong WZ; Yam AWY; Zhang T; Asamitsu K; Iida S; Okamoto T; Ueda R; Gray NS; Ishida T; Sanda T
Blood; 2017 Nov; 130(21):2326-2338. PubMed ID: 28978570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
